SSRI Birth Defect Lawsuits Continue To Be Filed Alleging Anti-Depressents Caused Heart Malformations Such As Persistent Pulmonary Hypertension Of The Newborn (PPHN) And Skeletal Defects Such As Spina Bifida.
Southern Med Law reports recent court documents show SSRI birth defect lawsuits continue to be filed over purported side-effects of SSRI antidepressant medications such as Zoloft and Paxil which the lawsuits claim cause birth defects. The law firm notes that 548 lawsuits are pending in the U.S. District Court, Eastern District of Pennsylvania where a multidistrict litigation (MDL) has been established for all federally filed Zoloft birth defects lawsuits. Additional Zoloft lawsuits have been filed in state courts across the country, including Missouri and Pennsylvania. Court records indicate that an MDL has not been established for Paxil birth defect lawsuits but individual claims have been filed against Paxil’s manufacturer, GlaxoSmithKline. The pending SSRI birth defect lawsuits allege that SSRI manufacturers knew that their drugs cause serious birth defects that include club foot, spina bifida, and heart defects such as Persistent Pulmonary Hypertension Of The Newborn (PPHN), atrial septal defects and ventral septal defects, but failed to warn doctors and their patients about this danger. (In re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation, MDL-2342)
“Dr. François Blaudeau, leader of the Southern Institute for Medical and Legal Affairs, has been monitoring the latest developments in SSRI lawsuit filings. Dr. Blaudeau is both an attorney and practicing physician and has first-hand knowledge of how SSRI medications affect expectant mothers and their infants.” – Southern Med Law
Dr. Blaudeau has been and is still advocating and representing clients in product liability and negligence lawsuits from around the country. For more SSRI birth defects lawsuits involving Zoloft or Paxil birth, and other product liability claims you can contact Dr. Francois Blaudeau for a free no-obligation case review by calling Phone: (205) 547-5525 or visiting www.southernmedlaw.com
According to court documents, the well-known anti-depressants Zoloft (sertraline chloride) and Paxil (paroxetine) are Selective Serotonin Reuptake Inhibitors (SSRI), which is a class of drugs that increase the amounts of serotonin, a natural chemical in the brain that helps maintain brain functions such as mood and memory. The court documents say that SSRI drugs are prescribed to treat such psychiatric conditions as depression, panic disorder, anxiety disorder, post-traumatic stress disorder and obsessive compulsive disorder. As stated in court documents and the U.S. Food and Drug Administration (FDA), the FDA in 2006 ordered manufacturers of SSRI medications to update their drugs’ safety labels to warn about the potential risk of PPHN in infants born to women who took SSRI medications after the 20th week of pregnancy. According to court documents, the FDA in 2007 further directed SSRI makers to update the black box warning on their drugs’ labeling to include warnings about increased risks of suicidal thinking and behavior in young adults 18 to 24 years old.
Court records show that SSRI birth defect lawsuits cite various studies showing the birth defects risks associated with the use of SSRI drugs. According to court documents, a 2006 study published in the New England Journal of Medicine (NEJM) indicated that infants born to women who took an SSRI during the third trimester of their pregnancy had a six-fold increased risk of being born with PPHN. The NEJM published another study in 2007 suggesting that infants whose mothers used SSRI’s during the first trimester of pregnancy were twice as likely to suffer heart defects, with the most common defects being ventricular outflow defects and septal defects, as stated in court records.
According to court documents, GlaxoSmithKline agreed in 2010 to settle about 200 individual Paxil birth defects lawsuits that allege the antidepressant medication caused birth defects. Court records also indicate that GlaxoSmithKline agreed to plead guilty and pay $3 billion to resolve the charges brought by the U.S. Department of Justice that included promoting the off-label use of certain prescription drugs, including Paxil, falsely reporting the best prices of its drugs, and paying kickbacks to doctors who prescribe the company’s various drugs.
[justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report, July 2012]
About Southern Med Law
Southern Med Law is a patient and consumer advocacy organization providing legal representation to the victims of negligent personal injuries, medical malpractice, dangerous drugs, faulty medical devices and defective products. Led by Dr. François Blaudeau, an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.
Southern Med Law
Southern Institute for Medical and Legal Affairs
2224 1st Ave., North
Birmingham, AL 35203
Phone: (205) 547-5525
Fax: (205) 547-5526